prednisone and Leukocytopenia studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research Excerpts

Excerpt	Relevance	Reference
"Enteropathy-type intestinal T-cell lymphoma (ETCL) is a highly aggressive disease with poor response to conventional CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy."	9.11	Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. ( Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S, 2004)
"Our study assessed the factors that predispose renal transplant recipients to the occurrence of thrombocytopenia and leukopenia, as well as the severity and the time- and concentration-dependence of these side-effects, after administration of sirolimus (SRL) in combination with a cyclosporine (CsA) and prednisone (Pred) regimen."	9.09	Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. ( Hong, JC; Kahan, BD, 2000)
"A total of 361 evaluable patients with previously untreated multiple myeloma were randomized to receive oral melphalan (0."	9.05	Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience. ( Brunner, K; Cooper, MR; Cornwell, GG; Cuttner, J; Glowienka, LP; Haurani, FI; Henderson, E; Kochwa, S; Kyle, RA; McIntyre, OR; Pajak, TF; Rafla, S; Silver, RT, 1982)
"Sixty-five patients with multiple myeloma resistant to melphalan were randomized to receive cyclophosphamide, doxorubicin (Adriamycin), and prednisone (CAP) (30 patients) or carmustine (BCNU), doxorubicin, and prednisone (BAP) (35 patients)."	9.05	Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone. ( Brunner, K; Henderson, ES; Henry, PH; Holland, JF; Kyle, RA; McIntyre, OR; Nawabi, IU; Pajak, TF, 1982)
"Bortezomib is a proteasome inhibitor that has shown important clinical efficacy either as a single agent or in combination in patients with multiple myeloma (MM)."	7.80	Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma. ( Andrea, M; Becker, C; Behre, G; Bourgeois, M; Edelmann, T; Gutsche, K; Hammerschmidt, D; Hennig, E; Heyn, S; Hoffmann, FA; Holzvogt, B; Kaiser, T; Krahl, R; Kreibich, U; Lindner, T; Niederwieser, D; Plötze, M; Pönisch, W; Reifenrath, K; Remane, Y; Schliwa, T; Schwarz, M; Schwarzer, A; Vucinic, V; Winkelmann, C; Zehrfeld, T, 2014)
"Five patients with a steroid-responsive, frequently relapsing nephrotic syndrome who had failed at least one course of treatment with cyclophosphamide were all put into a long term remission with chlorambucil."	7.67	Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. ( Bailey, RR, 1989)
"The pharmacokinetics of a 40-mg intravenous dose of prednisolone were determined in 10 steroid-dependent asthmatic children with highly variable prednisone requirements (5 mg every other day to 40 mg a day)."	7.66	Prednisolone disposition in steroid-dependent asthmatic children. ( Ellis, EF; Jusko, WJ; Middleton, E; Nickelsen, JA; Rose, JQ, 1981)
"From January 1975 to May 1981, 25 consecutive patients with multiple myeloma (MM) were entered in a prospective study and treated with the M-2 protocol (melphalan, prednisone, cyclophosphamide, vincristine, and carmustine [BCNU])."	7.66	Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol). ( Carbone, A; Crivellari, D; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A, 1982)
"A four-drug combination of intermittent high-dose cyclophosphamide with 5-fluorouracil, hexamethylmelamine, and prednisone was given to 19 patients with advanced breast cancer."	7.66	Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer. ( Chang, YC; Crowley, J; Falkson, G; Tormey, DC, 1981)
"Mycophenolate mofetil (MMF) combined with conventional cyclosporine and steroids doses efficiently prevents acute rejection in kidney transplants."	6.69	Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. ( Andrés, A; Cruzado, JM; Fulladosa, X; Gil-Vernet, S; Grinyó, JM; Morales, JM; Moreso, F; Pérez, JL; Serón, D, 1998)
"Enteropathy-type intestinal T-cell lymphoma (ETCL) is a highly aggressive disease with poor response to conventional CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy."	5.11	Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. ( Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S, 2004)
"Our study assessed the factors that predispose renal transplant recipients to the occurrence of thrombocytopenia and leukopenia, as well as the severity and the time- and concentration-dependence of these side-effects, after administration of sirolimus (SRL) in combination with a cyclosporine (CsA) and prednisone (Pred) regimen."	5.09	Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. ( Hong, JC; Kahan, BD, 2000)
"Sixty-five patients with multiple myeloma resistant to melphalan were randomized to receive cyclophosphamide, doxorubicin (Adriamycin), and prednisone (CAP) (30 patients) or carmustine (BCNU), doxorubicin, and prednisone (BAP) (35 patients)."	5.05	Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone. ( Brunner, K; Henderson, ES; Henry, PH; Holland, JF; Kyle, RA; McIntyre, OR; Nawabi, IU; Pajak, TF, 1982)
"A total of 361 evaluable patients with previously untreated multiple myeloma were randomized to receive oral melphalan (0."	5.05	Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience. ( Brunner, K; Cooper, MR; Cornwell, GG; Cuttner, J; Glowienka, LP; Haurani, FI; Henderson, E; Kochwa, S; Kyle, RA; McIntyre, OR; Pajak, TF; Rafla, S; Silver, RT, 1982)
"Two hundred fifty-two previously untreated evaluable patients with multiple myeloma were entered into a study testing a regimen of three intravenous alkylating agents, melphalan, cyclophosphamide, and carmustine (BCNU), given in combination (BCMP) against a regimen employing oral melphalan (MP)."	5.04	Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGB. ( Coleman, M; Cooper, MR; Cuttner, J; Harley, JB; Kochwa, S; McIntyre, OR; Pajak, TF, 1979)
"Clinical and/or biological risk factors are needed to identify elderly patients with aggressive B-cell lymphoma able to receive full-dose R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) treatment."	3.81	Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics. ( Auberger, J; Boekstegers, A; Egle, A; Greil, R; Hopfinger, G; Hufnagl, C; Kemmerling, R; Melchardt, T; Morre, P; Neureiter, D; Pleyer, L; Steinkirchner, S; Weiss, L, 2015)
"Bortezomib is a proteasome inhibitor that has shown important clinical efficacy either as a single agent or in combination in patients with multiple myeloma (MM)."	3.80	Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma. ( Andrea, M; Becker, C; Behre, G; Bourgeois, M; Edelmann, T; Gutsche, K; Hammerschmidt, D; Hennig, E; Heyn, S; Hoffmann, FA; Holzvogt, B; Kaiser, T; Krahl, R; Kreibich, U; Lindner, T; Niederwieser, D; Plötze, M; Pönisch, W; Reifenrath, K; Remane, Y; Schliwa, T; Schwarz, M; Schwarzer, A; Vucinic, V; Winkelmann, C; Zehrfeld, T, 2014)
"Five patients with a steroid-responsive, frequently relapsing nephrotic syndrome who had failed at least one course of treatment with cyclophosphamide were all put into a long term remission with chlorambucil."	3.67	Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. ( Bailey, RR, 1989)
" A matched case-control study of host risk factors showed that leukopenia, prior administration of antibiotics, and treatment with azathioprine and antilymphocyte serum were not significantly related to the development of aspergillosis."	3.66	Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. ( Gustafson, TL; Hutcheson, RH; Johnson, HK; Lavely, GB; Schaffner, W; Stratton, CW, 1983)
"From January 1975 to May 1981, 25 consecutive patients with multiple myeloma (MM) were entered in a prospective study and treated with the M-2 protocol (melphalan, prednisone, cyclophosphamide, vincristine, and carmustine [BCNU])."	3.66	Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol). ( Carbone, A; Crivellari, D; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A, 1982)
"Nineteen patients with advanced non-Hodgkin's lymphoma resistant to previous chemotherapy were treated with combination chemotherapy consisting of lomustine (CCNU), cytarabine, and prednisone."	3.66	Salvage chemotherapy for non-Hodgkin's lymphoma. ( Khoo, RK; Ng, PR; Todd, D, 1982)
"The pharmacokinetics of a 40-mg intravenous dose of prednisolone were determined in 10 steroid-dependent asthmatic children with highly variable prednisone requirements (5 mg every other day to 40 mg a day)."	3.66	Prednisolone disposition in steroid-dependent asthmatic children. ( Ellis, EF; Jusko, WJ; Middleton, E; Nickelsen, JA; Rose, JQ, 1981)
"A four-drug combination of intermittent high-dose cyclophosphamide with 5-fluorouracil, hexamethylmelamine, and prednisone was given to 19 patients with advanced breast cancer."	3.66	Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer. ( Chang, YC; Crowley, J; Falkson, G; Tormey, DC, 1981)
" Adverse events included neutropenia (92/76%), thrombocytopenia (70/10%) and leukopenia (65/50%)."	2.87	Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized ( Belch, A; Bosly, A; Bunworasate, U; Cavalli, F; Dascalescu, A; Drach, J; Farber, C; Huang, H; Masliak, Z; Novak, J; Pei, L; Robak, T; Rooney, B; Samoilova, O; van de Velde, H; Vilchevskaya, K; Zaucha, J, 2018)
" A randomized phase II study is under way to further compare toxicity and efficacy of the 2 dosing schedules."	2.76	Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma. ( Dumitrescu, O; Gerecitano, J; Hamlin, P; Horanlli, E; Iasonos, A; Mo, Q; Moskowitz, CH; Noy, A; O'Connor, OA; Pappanicholaou, J; Portlock, C; Rojas, CN; Sarasohn, D; Schulman, P; Straus, D; Zelenetz, AD; Zhang, Z, 2011)
" Adverse events were higher in everolimus-treated patients especially at the 4-mg/day dose, but there was no difference in the incidence of thrombocytopenia or leukopenia between all groups and renal function as determined by serum creatinine, and creatinine clearance remained stable to 36 months in everolimus-treated patients."	2.72	Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. ( Abecassis, M; Calmus, Y; Fischer, L; Freeman, R; Klempnauer, J; Langnas, A; Levy, G; Mayer, D; Nashan, B; Neuhaus, P; Punch, J; Roberts, J; Rogiers, X; Samuel, D; Schmidli, H; Sloof, M; Tuttle-Newhall, E, 2006)
" The purpose of this study was to explore the association between these polymorphisms and the occurrence of azathioprine adverse effects in 112 renal transplant recipients undergoing triple immunosuppressive therapy including azathioprine, cyclosporine, and prednisone."	2.71	The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. ( Domański, L; Droździk, M; Dziewanowski, K; Gawrońska-Szklarz, B; Kurzawski, M, 2005)
"Three patients had grade 3 infections."	2.71	Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study. ( Dührsen, U; Kasper, C; Müller-Beissenhirtz, H; Nückel, H, 2005)
"Mycophenolate mofetil (MMF) combined with conventional cyclosporine and steroids doses efficiently prevents acute rejection in kidney transplants."	2.69	Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. ( Andrés, A; Cruzado, JM; Fulladosa, X; Gil-Vernet, S; Grinyó, JM; Morales, JM; Moreso, F; Pérez, JL; Serón, D, 1998)
" Despite increased hematotoxicity, moderate dose escalation is safe for the majority of the patients with G-CSF assistance and standard supportive treatment."	2.69	Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG). ( Diehl, V; Engel, C; Loeffler, M; Schmitz, S; Tesch, H, 2000)
"Thirty-four children with Hodgkin's disease were treated during the years 1969--75."	2.64	MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children. ( Armata, J; Borkowski, W; Depowska, T; Depowski, M; Kaczor, Z; Stopyrowa, J; Strzeszynski, J, 1978)
"Leukopenia was the dose-limiting toxicity with all three regimens."	2.64	Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. ( Bonnet, JD; Braine, H; Costanzi, JJ; George, SL; Hoogstraten, B; Rivkin, SE; Samal, B; Thigpen, T, 1976)
"Azathioprine was hepatotoxic in doses of 200 mg daily or more."	2.64	Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients. ( Hahn, BH; Kantor, OS; Osterland, CK, 1975)
"Immune thrombocytopenic purpura is rarely reported in association with inflammatory bowel disease."	2.40	Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? ( Ammirati, M; Gruenstein, S; Kim, P; Korelitz, BI; Lipsey, L; Schwarz, S; Wisch, N; Zlatanic, J, 1997)
"Evans syndrome is defined as the simultaneous or sequential occurrence of Coombs' positive hemolytic anemia and immune thrombocytopenia without known underlying etiology."	2.37	Evans syndrome in childhood: pathophysiology, clinical course, and treatment. ( Wang, WC, 1988)
"Although G-CSF is widely used to prevent or ameliorate leukopenia during cytotoxic chemotherapies, its optimal use is still under debate and depends on many therapy parameters such as dosing and timing of cytotoxic drugs and G-CSF, G-CSF pharmaceuticals used and individual risk factors of patients."	1.48	Model-based optimization of G-CSF treatment during cytotoxic chemotherapy. ( Engel, C; Loeffler, M; Loibl, S; Schirm, S; Scholz, M, 2018)
"Fever was present in 76% of the cases, with a median duration of 9 days (IQR 0."	1.43	Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children. ( Choi, EH; Kang, HM; Kim, JY; Lee, H; Lee, HJ; Yun, KW, 2016)
"The progression from DLE to systemic lupus erythematosus has been reported in up to 28% of patients."	1.39	Pulmonary hemorrhage in a patient initially presenting with discoid lupus. ( Jiménez-Encarnación, E; Vilá, S; Vilá-Rivera, K, 2013)
"A 36-year-old woman with systemic lupus erythematosus was admitted to our hospital with malaise, myalgia, dysphagia, fever, preserved muscle strength, leukocytosis (15,600 cells), and increased creatine kinase of 1,358 IU/L that reached 75,000 IU/L in few days."	1.37	Fatal rhabdomyolysis in systemic lupus erythematosus. ( Bonfa, E; da Mota, LM; de Carvalho, JF, 2011)
"As no data on this topic exist for MALT lymphoma, we have retrospectively analysed our experience with R plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone (R-CHOP/R-CNOP) in patients with relapsed MALT lymphoma."	1.33	Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. ( Chott, A; Drach, J; Jager, U; Puspok, A; Raderer, M; Streubel, B; Troch, M; Turetschek, K; Wohrer, S; Zielinski, CC, 2006)
"Of 6 patients who developed recurrence, 3 (7."	1.33	[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006)
"Twenty-two per cent of patients discontinued azathioprine prematurely probably as a result of related adverse events."	1.32	Side effects of azathioprine in patients with Crohn's disease. ( de Jong, DJ; Goullet, M; Naber, TH, 2004)
"Grade 3-4 leukopenia was observed in 61% of patients with 11% of febrile neutropenia."	1.32	ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma. ( Cavalli, F; Cocorocchio, E; Conconi, A; De Luzio, K; Ferrucci, PF; Martinelli, G; Mazzetta, C; Mingrone, W; Peccatori, FA; Santoro, P; Zucca, E, 2003)
"Azathioprine treatment played only a minor role in the development of thrombocytopenia but patients with low (100-200 mio."	1.29	Bone marrow function during quadruple immunosuppressive therapy after renal transplantation. ( Heaf, J, 1993)
"The effectiveness of treatment of lymphosarcoma of lymph nodes with cyclophosphamide, vincristin (oncovin) and prednisolone (scheme COP) was found to depend on the cytomorphological type of tumor, stage and previous therapy, with duration of remission being in direct correlationship with its degree."	1.27	[Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone]. ( Abdyldaev, RA; Kruglova, GV, 1983)
"Twenty-three patients with metastatic breast carcinoma were induced with a complex systemic therapy regimen in an attempt to ascertain if a complete remission rate greater than 50% could be obtained with intensive drug exposure."	1.27	Short term high density systemic therapy for metastatic breast cancer. ( Carbone, PP; Davis, TE; Kline, JC; Love, RR; Palta, M; Tormey, DC, 1985)
"Anemia and leukopenia have been reported in sarcoidosis."	1.27	The anemia of sarcoidosis. ( Baughman, RP; Lower, EE; Martelo, OJ; Smith, JT, 1988)
"The incidence of infections increased significantly with polymorphonuclear leukocyte (PMN) counts below 0."	1.27	Factors influencing the incidence of infections in Felty's syndrome. ( Breedveld, FC; Cats, A; Fibbe, WE; Hermans, J; van der Meer, JW, 1987)
"One patient with Hodgkin's disease involving the liver is alive at 36 months with further therapy."	1.26	Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. ( Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC, 1980)
"Eleven patients with acute lymphocytic leukemia in relapse were treated with L-asparaginase and cytosine arabinoside (1-beta-D-arabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy."	1.26	L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone. ( Burgert, EO; Gilchrist, GS; Smithson, WA, 1979)
"Thirty-eight patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP)."	1.26	Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. ( Bloomfield, CD; Fortuny, I; Kennedy, BJ; Vosika, G; Weiss, RB, 1976)
"Azathioprine (Imuran) was administered to seven patients with ulcerative colitis suffering from a relapse which could not be controlled by adrenocortical steroids."	1.25	Treatment of ulcerative colitis with azathioprine. ( Gilon, E; Theodor, E; Waks, U, 1968)

Research

Studies (207)

Authors

Clinical Trials (6)

Trial Overview

Trial Outcomes

Toxicity of Participants Receiving Bortezomib, Rituximab, Cyclophosphamide, and Prednisone for Treatment of Non-Hodgkin's Lymphoma

Maximum Tolerated Dose

Timeframe	Studies, this research(%)	All Research%
pre-1990	134 (64.73)	18.7374
1990's	22 (10.63)	18.2507
2000's	32 (15.46)	29.6817
2010's	18 (8.70)	24.3611
2020's	1 (0.48)	2.80

Authors	Studies
Haraguchi, M	1
Harada, N	1
Watanabe, J	1
Yoshikawa, H	1
Shirai, Y	1
Komura, M	1
Koyama, M	1
Ito, J	1
Tsukune, Y	1
Horimoto, Y	1
Hayashi, T	1
Nagaoka, T	1
Uekusa, T	1
Takahashi, K	1
Schirm, S	1
Engel, C	3
Loibl, S	1
Loeffler, M	5
Scholz, M	2
Drach, J	3
Huang, H	1
Samoilova, O	1
Belch, A	1
Farber, C	1
Bosly, A	1
Novak, J	1
Zaucha, J	1
Dascalescu, A	1
Bunworasate, U	1
Masliak, Z	1
Vilchevskaya, K	1
Robak, T	2
Pei, L	1
Rooney, B	1
van de Velde, H	1
Cavalli, F	2
Hegerova, LT	1
Lin, Y	1
Vilá-Rivera, K	1
Jiménez-Encarnación, E	1
Vilá, S	1
Melchardt, T	1
Weiss, L	1
Hufnagl, C	1
Neureiter, D	1
Kemmerling, R	1
Morre, P	1
Boekstegers, A	1
Hopfinger, G	1
Auberger, J	1
Steinkirchner, S	1
Pleyer, L	1
Greil, R	1
Egle, A	1
Pönisch, W	1
Holzvogt, B	1
Plötze, M	1
Andrea, M	1
Bourgeois, M	1
Heyn, S	1
Zehrfeld, T	1
Hammerschmidt, D	1
Schwarz, M	1
Edelmann, T	1
Becker, C	1
Hoffmann, FA	1
Schwarzer, A	1
Kreibich, U	1
Gutsche, K	1
Reifenrath, K	1
Winkelmann, C	1
Krahl, R	1
Remane, Y	1
Hennig, E	1
Schliwa, T	1
Lindner, T	1
Kaiser, T	1
Vucinic, V	1
Behre, G	1
Niederwieser, D	1
Aaldriks, AA	1
Giltay, EJ	1
Nortier, JW	1
van der Geest, LG	1
Tanis, BC	1
Ypma, P	1
le Cessie, S	1
Maartense, E	1
Kang, HM	1
Kim, JY	1
Choi, EH	1
Lee, HJ	1
Yun, KW	1
Lee, H	1
Regunath, H	1
Rojas-Moreno, C	1
Olano, JP	1
Hammer, RD	1
Salzer, W	1
Niu, Y	1
Shi, YK	1
He, XH	1
Feng, FY	1
Zhou, LQ	2
Gu, DZ	1
Tang, Y	1
Leclair, SJ	1
Scarano, FJ	1
Sharma, R	1
Cunningham, D	1
Smith, P	1
Robertson, G	1
Dent, O	1
Clarke, SJ	1
Derenzini, E	1
Stefoni, V	1
Pellegrini, C	1
Fina, MP	1
Broccoli, A	1
Venturini, F	1
Gandolfi, L	1
Pileri, SA	1
Martelli, M	1
Petti, MC	1
Perrotti, A	1
De Renzo, A	1
Zaja, F	1
Baccarani, M	1
Zinzani, PL	1
Aksu, K	1
Cagirgan, S	1
Ozsan, N	1
Keser, G	1
Sahin, F	1
de Carvalho, JF	1
da Mota, LM	1
Bonfa, E	1
Zwick, C	1
Hartmann, F	1
Zeynalova, S	1
Pöschel, V	1
Nickenig, C	1
Reiser, M	1
Lengfelder, E	1
Peter, N	1
Schlimok, G	1
Schubert, J	1
Schmitz, N	1
Pfreundschuh, M	2
Gerecitano, J	1
Portlock, C	1
Hamlin, P	1
Moskowitz, CH	1
Noy, A	1
Straus, D	1
Schulman, P	1
Dumitrescu, O	1
Sarasohn, D	1
Pappanicholaou, J	1
Iasonos, A	1
Zhang, Z	1
Mo, Q	1
Horanlli, E	1
Rojas, CN	1
Zelenetz, AD	1
O'Connor, OA	1
Karmali, R	1
Larson, ML	1
Wooldridge, JE	1
Gregory, SA	2
O'Brien, T	1
Shammo, JM	1
Bueschel, K	1
Venugopal, P	2
Pantanelli, SM	1
Khalifa, YM	1
Nassiri, M	1
Robertson, MJ	1
Hertzberg, L	1
Czader, MB	1
van Boekel, GA	1
Volbeda, M	1
van den Hoogen, MW	1
Hilbrands, LB	1
Berden, JH	1
Gómez, HL	1
Samanéz, C	1
Campana, F	1
Neciosup, SP	1
Vera, L	1
Casanova, L	1
Leon, J	1
Flores, C	1
de Mendoza, FH	1
Casteñeda, CA	1
Pinto, JA	1
Vallejos, CS	1
Sieber, M	1
Bredenfeld, H	1
Josting, A	1
Reineke, T	1
Rueffer, U	1
Koch, T	1
Naumann, R	1
Boissevain, F	1
Koch, P	1
Worst, P	1
Soekler, M	1
Eich, H	1
Müller-Hermelink, HK	1
Franklin, J	1
Paulus, U	1
Wolf, J	1
Engert, A	1
Diehl, V	2
Martinelli, G	1
Ferrucci, PF	1
Mingrone, W	1
Cocorocchio, E	1
Conconi, A	1
Peccatori, FA	1
De Luzio, K	1
Santoro, P	1
Mazzetta, C	1
Zucca, E	1
Malliti, M	1
Junot, H	1
Fievet, MH	1
Gabarre, J	1
Taright, N	1
Vernant, JP	1
Thuillier, A	1
FRITZSCHE, D	1
RIETSCHEL, HG	1
KOSHEL, IV	1
FREIREICH, EJ	2
LEVIN, RH	1
WHANG, J	1
CARBONE, PP	3
BRONSON, W	1
MORSE, EE	1
MYKHAMEDZIANOVA, GS	1
FLEISCHER, J	1
FIGUEROA, JE	1
NAKAMOTO, S	2
POUTASSE, EF	1
KOLFF, WJ	1
GOLDMAN, R	1
GOODWIN, WE	1
KAUFMAN, JJ	1
MARTIN, DC	1
GLASSOCK, RJ	1
NOUROK, DS	1
LOGE, JP	1
ROENIGK, HH	2
HASERICK, JR	1
MCCORMACK, LJ	1
Lehman, TJ	1
Edelheit, BS	1
Onel, KB	1
Buchheidt, D	1
Hummel, M	1
Diehl, S	1
Hehlmann, R	1
de Jong, DJ	1
Goullet, M	1
Naber, TH	1
du Buf-Vereijken, PW	1
Wetzels, JF	1
Wöhrer, S	2
Chott, A	2
Püspök, A	2
Hejna, M	1
Hoffmann, M	1
Raderer, M	2
Yamanaka, R	1
Morii, K	1
Shinbo, Y	1
Takeuchi, S	1
Tamura, T	1
Hondoh, H	1
Takahashi, H	2
Onda, K	1
Tanaka, R	1
Hou, M	1
Li, L	1
Qiu, M	1
Yan, X	1
Zhu, J	1
Gou, HF	1
Müller-Beissenhirtz, H	1
Kasper, C	1
Nückel, H	1
Dührsen, U	1
Kurzawski, M	1
Dziewanowski, K	1
Gawrońska-Szklarz, B	1
Domański, L	1
Droździk, M	1
Enschede, SH	1
Porter, C	1
Gruber, SA	1
West, MS	1
Sillix, DH	1
El-Amm, JM	1
Garnick, J	1
Morawski, K	1
Haririan, A	1
Wu, HJ	1
Zhang, QY	1
Chen, DF	1
Guan, XJ	1
Zhang, BL	1
Ma, J	1
Levy, G	1
Schmidli, H	1
Punch, J	1
Tuttle-Newhall, E	1
Mayer, D	1
Neuhaus, P	1
Samuel, D	1
Nashan, B	1
Klempnauer, J	1
Langnas, A	1
Calmus, Y	1
Rogiers, X	1
Abecassis, M	1
Freeman, R	1
Sloof, M	1
Roberts, J	1
Fischer, L	1
Xia, ZJ	2
Wang, FH	2
Huang, HQ	2
Luo, HY	1
Li, YH	2
Lin, TY	2
Jiang, WQ	2
Guan, ZZ	2
Bu, Q	1
Lin, XB	1
Peng, YL	1
Pan, ZH	1
Wang, SS	1
Wang, WH	1
Li, YX	1
Song, YW	1
Jin, J	1
Liu, YP	1
Wang, SL	1
Liu, XF	1
Yu, ZH	1
Han, JZ	1
Streubel, B	1
Jager, U	1
Turetschek, K	1
Troch, M	1
Zielinski, CC	1
Kim, JG	1
Sohn, SK	1
Chae, YS	1
Cho, YY	1
Yang, DH	1
Lee, JJ	1
Kim, HJ	1
Shin, HJ	1
Chung, JS	1
Cho, GJ	1
Lee, WS	1
Joo, YD	1
Sohn, CH	1
Oh, SJ	1
Fernández, AB	1
Weiss, DJ	1
Henson, M	1
Ziepert, M	1
Schmits, R	1
Trümper, L	1
Finkel, HE	1
Kimber, RJ	1
Dameshek, W	1
Rodgers, RW	1
Gamble, JF	2
Loh, KK	1
Shullenberger, CC	2
Bonnet, JD	3
Alexanian, R	1
Salmon, SE	1
Haut, A	1
Dixon, DO	1
Balentine, L	1
Skikne, BS	1
Park, CH	1
Lynch, SR	2
Harisdangkul, V	1
Barnes, TY	1
Songcharoen, S	1
Pennebaker, JB	1
Oken, MM	1
Costello, WG	1
Johnson, GJ	1
Lenhard, RE	1
Ezdinli, EZ	2
Orlow, E	1
Barnes, JM	1
Berard, CW	1
Glick, JH	2
Garay, G	1
Milone, J	1
Dibar, E	1
Pavlovsky, S	1
Kvicala, R	1
Sackmann Muriel, F	1
Montres Varela, D	1
Eppinger-Helft, M	1
Gustafson, TL	1
Schaffner, W	1
Lavely, GB	1
Stratton, CW	1
Johnson, HK	1
Hutcheson, RH	1
Tormey, DC	4
Weinberg, VE	1
Leone, LA	1
Glidewell, OJ	1
Perloff, M	1
Kennedy, BJ	2
Cortes, E	1
Silver, RT	3
Weiss, RB	2
Aisner, J	1
Pinnamaneni, K	1
Yap, HY	1
Buzdar, AU	1
Distefano, A	1
Blumenschein, GR	1
Bogusławska-Jaworska, J	1
Kościelniak, E	1
Sroczyńska, M	1
Sońta-Jakimczyk, D	1
Armata, J	2
Balwierz, W	1
Ciepielewska, D	1
Kaczmarek-Kanold, M	1
Ochocka, M	1
Radwańska, U	1
Krykowski, E	1
Płuzańska, A	1
Olszańska-Skorek, T	1
Urbańska-Ryś, H	1
Polkowska-Kulesza, E	1
Błasińska-Morawiec, M	1
Mazurowa, A	1
Fisher, RI	1
DeVita, VT	3
Hubbard, SM	1
Longo, DL	1
Wesley, R	1
Chabner, BA	1
Young, RC	1
Brahn, E	1
Helfgott, SM	1
Belli, JA	1
Anderson, RJ	2
Reinherz, EL	1
Schlossman, SF	1
Austen, KF	1
Trentham, DE	1
Rubin, L	1
Urowitz, MB	1
Pruzanski, W	1
Waibel, PJ	1
Jungi, WF	1
Senn, HJ	1
Abdyldaev, RA	1
Kruglova, GV	1
Wagener, DJ	1
Burgers, JM	1
Dekker, AW	1
Kazem, I	1
van Peperzeel, HA	1
Qasim, MM	1
Sizoo, W	1
Somers, R	1
Kroese, WF	1
Sweet, DL	1
Golomb, HM	1
Chang, YC	1
Falkson, G	2
Crowley, J	1
Monti, G	1
Cereda, UG	1
Pessina, E	1
De Micheli, N	1
Grisetti, GC	1
Invernizzi, F	1
Tirelli, U	1
Crivellari, D	1
Carbone, A	1
Veronesi, A	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Randomized Phase II Study About the Application of Pegfilgrastim (Neulasta) at Day 2 or Day 4 Within the Treatment in Patients With Aggressive Non-Hodgkin's Lymphoma Aged 61 to 80 Years With 6 or 8 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxor[NCT00726700]	Phase 2	109 participants (Actual)	Interventional	2004-05-31	Completed
A Phase II Study of the Novel Proteasome Inhibitor Bortezomib in Combination With Rituximab, Cyclophosphamide and Prednisone in Patients With Relapsed/Refractory Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)[NCT00295932]	Phase 1/Phase 2	79 participants (Actual)	Interventional	2005-12-13	Completed
A Randomized Prospective Trial of Conversion to Everolimus Therapy From Calcineurin Inhibitor Based Maintenance Immunosuppression in Association With Mycophenolic Acid in Liver Transplantation: Examination of Impact on Long Term Renal Function.[NCT01936519]		24 participants (Actual)	Interventional	2013-12-16	Completed
Hit Hard and Early. The Effect of High Dose Methylprednisolone on Nailfold Capillary Changes and Biomarkers in Early SSc: a 12-week Randomised Explorative Double-blind Placebo-controlled Trial.[NCT03059979]	Early Phase 1	30 participants (Anticipated)	Interventional	2017-01-31	Recruiting
A Prospective, Open, Randomized Controlled, Multi-center Phase III Clinical Trial Comparing High-dose Epirubicin and Standard-dose Epirubicin in R±CEOP in Newly Diagnosed Young Patients With Medium/High-risk Diffuse Large B-cell Lymphoma[NCT03151044]	Phase 3	408 participants (Anticipated)	Interventional	2016-07-31	Recruiting
Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial[NCT00001250]	Phase 2	130 participants	Interventional	1989-12-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Intervention	Participants (Count of Participants)
1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide	4
1.6 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide	6
1.6 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide	3
1.8 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide	4
Dose Level 1- 1.0 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid	2
Dose Level 2 - 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid	18
Dose Level 3 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham	3
Dose Level 4 - 1.5 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphami	4
Dose Level 5 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham	10
Weekly Bortezomib Dosing Schedule	12
Twice-weekly Bortezomib Dosing Schedule	13

Maximum tolerated dose of Bortezomib in combination with Rituximab, Cyclophosphamide and Prednisone in Phase I participants (NCT00295932)
Timeframe: 2 years

Recipient and Donor Genotyping for Selected Variants of CYP3A5, ABCB1 (MDR1), and CYP4A Genes

Intervention	mg/m^2 of Bortezomib (Number)
	Weekly Bortezomib	Twice-Weekly Bortezomib
Arm I	1.8	1.5

A blood sample was obtained from recipients and donors to measure gene polymorphism effects on metabolism of calcineurin inhibitor and everolimus. The polymorphisms are represented as the number of SNP occurrences for the CYP3A5, ABCB1 (MDR1) gene, and CYP4A4*22 genes. (NCT01936519)
Timeframe: 2 years

Renal Function as Measured by 24 Hour Urine Creatinine Clearance

Intervention	Participants (Count of Participants)
	Recipient Genotypes : rs776746 (CYP3A5 gene)	Recipient Genotypes : rs1045642 (ABCB1 gene)	Recipient Genotypes : rs1128503 (ABCB1 gene)	Recipient Genotypes : rs2032582 (ABCB1 gene)	Recipient Genotypes : rs35599367 (CYP4A4*22 gene)	Donor Genotypes : rs776746 (CYP3A5 gene)	Donor Genotypes : rs1045642 (ABCB1 gene)	Donor Genotypes : rs1128503 (ABCB1 gene)	Donor Genotypes : rs2032582 (ABCB1 gene)	Donor Genotypes : rs35599367 (Cyp4A4*22)
Calcineurin Inhibitor and Mycophenolic Acid	11	6	7	1	1	3	1	0	0	0
Everolimus and Mycophenolic Acid	11	6	8	0	1	0	5	0	0	1

Renal Function was assessed by 24 hr urine collection creatinine clearance measured (mL/min). 24 Hr urine collection was assessed at baseline, 6 months, 1 year, and 2 years post transplant. (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years

Renal Function as Measured by Cockcroft Gault Creatinine Clearance

Intervention	mL/min (Mean)
	24hr Urine Creatinine Clearance at 6 months	24hr Urine Creatinine Clearance at 1 year	24hr Urine Creatinine Clearance at 2 years
Calcineurin Inhibitor With Mycophenolic Acid	68.09	68.09	61.54
Everolimus With Mycophenolic Acid	70.75	86.8	90.63

The Cockcroft-Gault formula for estimating creatinine clearance was determined at 6 months, 1 year, and 2 years post transplant (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years

Renal Function as Measured by Iothalamate Clearance

Intervention	mL/min/1.73m2 (Mean)
	Cockcroft Gault Creatinine Clearance at 6 months	Cockcroft Gault Creatinine Clearance at 1 year	Cockcroft Gault Creatinine Clearance at 2 years
Calcineurin Inhibitor and Mycophenolic Acid	79.84	86.84	80.85
Everolimus and Mycophenolic Acid	100.17	113.47	108.16

Iothalamate Clearance was assessed at 6 months, 1 year, and 2 years post transplant. (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years

Renal Function as Measured by Modification of Diet in Renal Disease (MDRD) Estimated Glomerular Filtration Rate (eGFR)

Intervention	mL/min/1.73m2 (Mean)
	Iothalamate Clearance at 6 months	Iothalamate Clearance at 1 year	Iothalamate Clearance at 2 years
Calcineurin Inhibitor and Mycophenolic Acid	67.99	66.65	57.19
Everolimus and Mycophenolic Acid	74.23	104.01	79.41

Modification of Diet in Renal Disease (MDRD) estimated Glomerular Filtration Rate (eGFR) was assessed at 6 months, 1 year, and 2 years post transplant. (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years

Renal Function as Measured by Serum Creatinine Level

Intervention	mL/min/1.73 m2 (Mean)
	MDRD eGFR at 6 months	MDRD eGFR at 1 year	MDRD eGFR at 2 years
Calcineurin Inhibitor and Mycophenolic Acid	62.18	60.63	53.29
Everolimus and Mycophenolic Acid	81.27	88.01	87.37

Serum creatinine levels were assessed at 6 months, 1 year, and 2 years post transplant (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years

Intervention	mg/dL (Mean)
	Serum Creatinine at 6 months	Serum Creatinine at 1 year	Serum Creatinine at 2 years
Calcineurin Inhibitor and Mycophenolic Acid	1.29	1.29	1.51
Everolimus and Mycophenolic Acid	1.02	0.95	0.95

Article	Year
Primary effusion anaplastic large cell lymphoma in a patient with long-standing dermatitis herpetiformis and celiac disease. Annals of hematology, 2013, Volume: 92, Issue:2 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Cyclophosphamide; Derm	2013
Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? The American journal of gastroenterology, 1997, Volume: 92, Issue:12 Topics: Adolescent; Adult; Anemia; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Female; Hum	1997
[Chemotherapy of malignant lymphomas]. Fortschritte der Medizin, 1978, Jun-08, Volume: 96, Issue:22 Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Neoplasm	1978
Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature. Medicine, 1992, Volume: 71, Issue:2 Topics: Adult; Anemia, Hemolytic; Blotting, Southern; Bone Marrow Transplantation; Chromosome Mapping; Diagn	1992
Evans syndrome in childhood: pathophysiology, clinical course, and treatment. The American journal of pediatric hematology/oncology, 1988,Winter, Volume: 10, Issue:4 Topics: Adolescent; Anemia, Hemolytic, Autoimmune; Child; Child, Preschool; Coombs Test; Danazol; Female; Hu	1988
Management of the nephrotic syndrome. Clinical pediatrics, 1974, Volume: 13, Issue:1 Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Clinical Trials as Topic; Cyclophos	1974
Organ transplantation-today and tomorrow. The Chicago Medical School quarterly, 1969, Volume: 28, Issue:1 Topics: Animals; Antilymphocyte Serum; Azathioprine; Dogs; Drainage; Ethics, Medical; Heart Transplantation;	1969
[New principles of treatment in acute leukemia]. Ugeskrift for laeger, 1970, Apr-30, Volume: 132, Issue:18 Topics: Adolescent; Adult; Antineoplastic Agents; Central Nervous System Diseases; Child; Cyclophosphamide;	1970
Glucocorticoids in haematology. Acta medica Scandinavica. Supplementum, 1969, Volume: 500 Topics: Adult; Agranulocytosis; Anemia, Hemolytic, Autoimmune; Antibodies; Blood Cell Count; Blood Cells; Ch	1969

Article	Year
Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized Leukemia & lymphoma, 2018, Volume: 59, Issue:4 Topics: Adult; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Pro	2018
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO. BMC cancer, 2009, May-18, Volume: 9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; D	2009
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma. Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo	2009
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:8 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Resp	2011
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Apr-15, Volume: 17, Issue:8 Topics: Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boro	2011
Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lym Leukemia & lymphoma, 2011, Volume: 52, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antibodies, Monoclonal, Murine-Derived; Antineoplas	2011
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival. Hematology/oncology and stem cell therapy, 2012, Volume: 5, Issue:3 Topics: Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamid	2012
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9 Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphami	2003
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:11 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide;	2004
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophos	2005
Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study. Annals of hematology, 2005, Volume: 84, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; D	2005
The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Therapeutic drug monitoring, 2005, Volume: 27, Issue:4 Topics: Adolescent; Adult; Aged; Alleles; Azathioprine; Bone Marrow Diseases; Child; Cyclosporine; Dose-Resp	2005
Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma. Clinical advances in hematology & oncology : H&O, 2004, Volume: 2, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Pr	2004
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:11 Topics: Adult; Cholesterol; Cholesterol, LDL; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Do	2006
Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1 Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neo	2007
Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse. Cancer chemotherapy and pharmacology, 1983, Volume: 10, Issue:3 Topics: Adolescent; Adult; Anemia; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic;	1983
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study. American journal of clinical oncology, 1984, Volume: 7, Issue:3 Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials	1984
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. American journal of clinical oncology, 1982, Volume: 5, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clin	1982
Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone. Cancer treatment reports, 1982, Volume: 66, Issue:3 Topics: Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Therap	1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience. Cancer, 1982, Nov-01, Volume: 50, Issue:9 Topics: Antineoplastic Agents; Carmustine; Drug Administration Schedule; Drug Therapy, Combination; Female;	1982
The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. Blood, 1981, Volume: 58, Issue:3 Topics: Aged; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leukopenia; Lymphoma	1981
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici	1995
Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorouracil;	1993
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group. Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy,	1998
Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. Clinical transplantation, 1998, Volume: 12, Issue:3 Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Clinical Trials as Topic; Cyclosporine; Cytom	1998
Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. Transplantation, 2000, May-27, Volume: 69, Issue:10 Topics: Adolescent; Adult; Aged; Cadaver; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; H	2000
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG). Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets;	2000
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes. Leukemia, 2000, Volume: 14, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cinchona Alkaloids; Cyclophosphamide; D	2000
Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata. The British journal of cancer. Supplement, 1975, Volume: 2 Topics: Antineoplastic Agents; Bleomycin; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Doxorubic	1975
Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia. Medical and pediatric oncology, 1977, Volume: 3, Issue:4 Topics: Adolescent; Adult; Anaphylaxis; Asparaginase; Child; Clinical Trials as Topic; Dexamethasone; Drug A	1977
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children. Acta paediatrica Scandinavica, 1978, Volume: 67, Issue:3 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluatio	1978
Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGB. Blood, 1979, Volume: 54, Issue:1 Topics: Alkylating Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Leukopenia; Melp	1979
Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. Cancer, 1976, Volume: 38, Issue:1 Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; D	1976
Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients. Annals of internal medicine, 1975, Volume: 83, Issue:5 Topics: Adolescent; Adult; Antibodies, Antinuclear; Azathioprine; Clinical Trials as Topic; Drug Therapy, Co	1975
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici	1992
Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group. Japanese journal of clinical oncology, 1991, Volume: 21, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Binomial Distribution; Carcinoma, Small	1991
Waldenström's macroglobulinemia: long-term results with the M-2 protocol. Cancer investigation, 1991, Volume: 9, Issue:1 Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dru	1991
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Follow-Up Stud	1985
Treatment of multiple myeloma: a randomized study of three different regimens. Leukemia research, 1985, Volume: 9, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Carmustine; Clinical Trials as	1985
Acute lymphocytic leukemia in childhood. Seminars in hematology, 1974, Volume: 11, Issue:1 Topics: Asparaginase; Black People; Bone Marrow Examination; Central Nervous System Diseases; Child; Child,	1974
Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. Archives of internal medicine, 1974, Volume: 133, Issue:2 Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Anemia; Chemical and Drug Induced Liver Injury;	1974
Azathioprine in the treatment of Crohn's disease. The British journal of surgery, 1972, Volume: 59, Issue:10 Topics: Azathioprine; Clinical Trials as Topic; Colic; Crohn Disease; Humans; Leukopenia; Lymphoma; Placebos	1972
Management of the nephrotic syndrome. Clinical pediatrics, 1974, Volume: 13, Issue:1 Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Clinical Trials as Topic; Cyclophos	1974
Toxicity of L-asparginase in children with advanced leukemia. Cancer, 1972, Volume: 30, Issue:2 Topics: Acute Disease; Antineoplastic Agents; Asparaginase; Central Nervous System Diseases; Chemical and Dr	1972
A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. The Journal of pediatrics, 1973, Volume: 82, Issue:4 Topics: Adolescent; Alopecia; Child; Cyclophosphamide; Cystitis; Drug Synergism; Female; Humans; Hypercholes	1973
Evaluation of aniline mustard in patients with multiple myeloma. Cancer research, 1973, Volume: 33, Issue:5 Topics: Adult; Aged; Aniline Compounds; Female; Hematocrit; Humans; Leukocyte Count; Leukopenia; Male; Middl	1973

Article	Year
Disseminated nontuberculous mycobacteriosis and fungemia after second delivery in a patient with MonoMAC syndrome/GATA2 mutation: a case report. BMC infectious diseases, 2021, May-29, Volume: 21, Issue:1 Topics: Adult; Anti-Bacterial Agents; Fatal Outcome; Female; Fungemia; GATA2 Deficiency; GATA2 Transcription	2021
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy. Journal of cancer research and clinical oncology, 2018, Volume: 144, Issue:2 Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo	2018
Disseminated histoplasmosis: a cause of hemophagocytic syndrome. Mayo Clinic proceedings, 2013, Volume: 88, Issue:10 Topics: Adult; Anemia; Anti-Bacterial Agents; Anti-Inflammatory Agents; Asthma; Bone Marrow Cells; Erythroid	2013
Pulmonary hemorrhage in a patient initially presenting with discoid lupus. Puerto Rico health sciences journal, 2013, Volume: 32, Issue:4 Topics: Adult; Anti-Bacterial Agents; Biopsy; Bronchopneumonia; Diagnostic Errors; Disease Progression; Dysp	2013
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics. Leukemia & lymphoma, 2015, Volume: 56, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Alcohol Oxidoreductases; Antineoplast	2015
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma. Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydroch	2014
Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma. Leukemia & lymphoma, 2015, Volume: 56, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic	2015
Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children. The Journal of pediatrics, 2016, Volume: 171 Topics: Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Child; Electronic Health Records; Female	2016
Early diagnosis of Ehrlichia ewingii infection in a lung transplant recipient by peripheral blood smear. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:2 Topics: Aged; Animals; Anti-Bacterial Agents; Cytodiagnosis; Disease Transmission, Infectious; DNA, Bacteria	2017
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:8 Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child;	2008
Septicemic arthritis with antibiotic resistance: a case study. Clinical laboratory science : journal of the American Society for Medical Technology, 2008,Fall, Volume: 21, Issue:4 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Bacte	2008
Non-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis. Rheumatology international, 2011, Volume: 31, Issue:12 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy	2011
Fatal rhabdomyolysis in systemic lupus erythematosus. Rheumatology international, 2011, Volume: 31, Issue:9 Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Antibodies, Antinuclear; Arthritis; Azathioprine;	2011
Cytomegalovirus colitis and viremia from mycophenolate mofetil monotherapy in birdshot chorioretinopathy. Ocular immunology and inflammation, 2011, Volume: 19, Issue:6 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Birdshot Chorioretinopathy; CD4 Ly	2011
Idiopathic giant oesophageal ulcer and leucopoenia after renal transplantation. The Netherlands journal of medicine, 2012, Volume: 70, Issue:8 Topics: Antibodies, Monoclonal, Murine-Derived; Esophageal Diseases; Humans; Immunologic Factors; Kidney Tra	2012
ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma, 2003, Volume: 44, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic	2003
[Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy]. Annales de medecine interne, 2003, Volume: 154, Issue:3 Topics: Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem	2003
[The problem of leukopenia as a side-effect of intravenous long-term therapy of malignant tumors and leukoses with endoxan]. Medizinische Klinik, 1962, Aug-31, Volume: 57 Topics: Blood Transfusion; Cyclophosphamide; Humans; Leukemia; Leukopenia; Neoplasms; Prednisolone; Predniso	1962
[CHANGES IN THE PERIPHERAL BLOOD INDICES OF CHILDREN WITH ACUTE LEUKEMIAS DURING STEROID HORMONE THERAPY]. Pediatriia, 1963, Volume: 42 Topics: Adolescent; Adrenal Cortex Hormones; Antimetabolites; Antineoplastic Agents; Child; Dexamethasone; H	1963
THE FUNCTION AND FATE OF TRANSFUSED LEUKOCYTES FROM DONORS WITH CHRONIC MYELOCYTIC LEUKEMIA IN LEUKOPENIC RECIPIENTS. Annals of the New York Academy of Sciences, 1964, Feb-28, Volume: 113 Topics: Anti-Bacterial Agents; Blood Transfusion; Cell Division; Humans; Leukemia; Leukemia, Myelogenous, Ch	1964
[CONGENITAL HYPOPLASTIC STATE OF THE HEMATOPOIETIC SYSTEM IN CHILDREN]. Pediatriia, 1963, Volume: 42 Topics: Anemia; Anemia, Aplastic; Ascorbic Acid; Bilirubin; Blood Cell Count; Blood Chemical Analysis; Blood	1963
[DOES PROLONGED ADMINISTRATION OF PREDNISONE HAVE A BONE MARROW-STIMULATING EFFECT?]. Die Medizinische Welt, 1964, Apr-18, Volume: 16 Topics: Bone Marrow; Cyclophosphamide; Leukocyte Disorders; Leukopenia; Prednisolone; Prednisone; Rabbits; R	1964
RENAL HOMOTRANSPLANTATION IN MAN; REPORT OF SIX CONSECUTIVE CASES. Annals of internal medicine, 1964, Volume: 61 Topics: Adolescent; Anuria; Azathioprine; Blood Chemical Analysis; Dactinomycin; Drug Therapy; Hypertension;	1964
SIXTEEN CASES OF RENAL HOMOTRANSPLANTATION . Archives of internal medicine, 1964, Volume: 114 Topics: Anuria; Azathioprine; Blood Group Incompatibility; Dactinomycin; Glomerulonephritis; Hypertension; I	1964
APLASTIC ANEMIA FOLLOWING EXPOSURE TO BENZENE HEXACHLORIDE (LINDANE). JAMA, 1965, Jul-12, Volume: 193 Topics: Agranulocytosis; Anemia; Anemia, Aplastic; Child; Chlordan; DDT; Diagnosis; Drug Therapy; Ecchymosis	1965
SYSTEMIC LUPUS ERYTHEMATOSUS AND RENAL TRANSPLANTATION: REPORT OF TWO CASES. Archives of dermatology, 1965, Volume: 92 Topics: Adolescent; Azathioprine; Humans; Kidney; Kidney Transplantation; Kidneys, Artificial; Leukopenia; L	1965
Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Annals of the rheumatic diseases, 2004, Volume: 63, Issue:3 Topics: Blood Proteins; Chronic Disease; Complement C3; Creatinine; Cyclophosphamide; Drug Therapy, Combinat	2004
Fatal cerebral involvement in systemic aspergillosis: a rare complication of steroid-treated autoimmune bicytopenia. European journal of haematology, 2004, Volume: 72, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Autoimmune Diseases;	2004
Side effects of azathioprine in patients with Crohn's disease. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:2 Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents; Azathioprine; Chemical and Drug Induced Liver In	2004
Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:8 Topics: Adult; Aged; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immu	2004
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma. Annals of hematology, 2005, Volume: 84, Issue:7 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Centra	2005
Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients. Surgery, 2005, Volume: 138, Issue:4 Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Biopsy; Black or African American; Case-Control Studi	2005
[Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:12 Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; A	2005
Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoenia. British journal of haematology, 2006, Volume: 132, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide	2006
[Efficacy of rituximab-containing regimens on indolent B-cell lymphoma--a report of 34 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents;	2006
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineo	2006
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit	2006
Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. Oncology, 2006, Volume: 70, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti	2006
An unusual case of autoimmune hemolytic anemia in treatment naïve hepatitis C virus infection. Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:5 Topics: Adult; Anemia, Hemolytic, Autoimmune; Female; Hepatitis C; Humans; Leukopenia; Neutropenia; Pancytop	2006
Pure white cell aplasia in a dog. Veterinary clinical pathology, 2007, Volume: 36, Issue:4 Topics: Animals; Dog Diseases; Dogs; Immunosuppressive Agents; Leukopenia; Prednisone	2007
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophospham	2008
Corticosteroid-responsive acquired pure red cell aplasia in adults. The American journal of medicine, 1967, Volume: 43, Issue:5 Topics: Aged; Anemia, Aplastic; Cortisone; Erythropoiesis; Female; Hemoglobinometry; Humans; Leukopenia; Mal	1967
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. Cancer, 1980, Dec-01, Volume: 46, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administra	1980
Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study. Cancer treatment reports, 1984, Volume: 68, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Doxorubicin; Drug	1984
Malignant lymphocytic lymphoma. Demonstration of a serum inhibitor of myelopoiesis and response to combination chemotherapy. Cancer, 1983, Jul-01, Volume: 52, Issue:1 Topics: Antineoplastic Agents; Colony-Forming Units Assay; Cyclophosphamide; Drug Therapy, Combination; Hema	1983
Clinical significance of low molecular weight IgM in patients with systemic lupus erythematosus. The Journal of rheumatology, 1984, Volume: 11, Issue:5 Topics: Adult; Antibodies, Antinuclear; DNA; Female; Follow-Up Studies; Hemoglobinometry; Humans; Immunoglob	1984
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimen. Cancer, 1983, May-01, Volume: 51, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide;	1983
Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. The Journal of infectious diseases, 1983, Volume: 148, Issue:2 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antilymphocyte Serum; Aspergillosis; Aspergillus fum	1983
Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone. Cancer, 1984, May-01, Volume: 53, Issue:9 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neopla	1984
Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group. The American journal of pediatric hematology/oncology, 1984,Winter, Volume: 6, Issue:4 Topics: Abdominal Neoplasms; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syste	1984
[Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Apr-18, Volume: 38, Issue:16 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-	1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Annals of internal medicine, 1983, Volume: 98, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bloo	1983
Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup. Arthritis and rheumatism, 1984, Volume: 27, Issue:5 Topics: Adult; Aged; Anemia, Aplastic; Arthritis, Rheumatoid; Blood Transfusion; Bone Marrow; Drug Resistanc	1984
Systemic lupus erythematosus with paraproteinemia. Arthritis and rheumatism, 1984, Volume: 27, Issue:6 Topics: Adult; Aged; Antibodies, Antinuclear; Azathioprine; Female; Glomerulonephritis; Glycoproteins; HLA A	1984
[Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment]. Deutsche medizinische Wochenschrift (1946), 1983, Dec-02, Volume: 108, Issue:48 Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Cyclophosp	1983
[Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone]. Voprosy onkologii, 1983, Volume: 29, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Humans;	1983
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV. Cancer, 1983, Nov-01, Volume: 52, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;	1983
The treatment of histiocytic lymphoma. Seminars in oncology, 1980, Volume: 7, Issue:3 Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Leucovorin; Leukopenia; Ly	1980
Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer. Cancer clinical trials, 1981,Winter, Volume: 4, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide;	1981
[Therapy of multiple myeloma. Study of hospital patients: 81 cases in 16 years' observation]. Minerva medica, 1983, Feb-11, Volume: 74, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leu	1983
Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol). Cancer treatment reports, 1982, Volume: 66, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cycl	1982
VP-16 and adriamycin in patients with advanced breast cancer. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla	1982
Salvage chemotherapy for non-Hodgkin's lymphoma. Cancer treatment reports, 1982, Volume: 66, Issue:11 Topics: Adult; Aged; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Lymphoma;	1982
Long-term assessment of chlorambucil in children with nephrotic syndrome who fail to respond adequately to corticosteroids. Contributions to nephrology, 1981, Volume: 27 Topics: Adolescent; Anemia; Bacterial Infections; Child; Child, Preschool; Chlorambucil; Drug Resistance; Fe	1981
Connective tissue panniculitis. Archives of dermatology, 1980, Volume: 116, Issue:3 Topics: Adipose Tissue; Adolescent; Adult; Antigen-Antibody Reactions; Atrophy; Biopsy; Connective Tissue Di	1980
Prednisolone disposition in steroid-dependent asthmatic children. The Journal of allergy and clinical immunology, 1981, Volume: 67, Issue:3 Topics: Aging; Asthma; Child; Dose-Response Relationship, Drug; Eosinophils; Female; Humans; Leukopenia; Mal	1981
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplat	1993
[Appropriate administration of granulocyte colony stimulating factor for malignant lymphoma of the head and neck]. Nihon Jibiinkoka Gakkai kaiho, 1993, Volume: 96, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubi	1993
Bone marrow function during quadruple immunosuppressive therapy after renal transplantation. Clinical nephrology, 1993, Volume: 40, Issue:6 Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy;	1993
Mycophenolate mofetil in liver transplantation. Clinical transplantation, 1996, Volume: 10, Issue:1 Pt 2 Topics: Administration, Oral; Adolescent; Adult; Cyclosporine; Cytomegalovirus Infections; Diarrhea; Female;	1996
Granulocyte-colony stimulating factor fails to prevent leucopenia caused by CEMP in elderly patients with aggressive lymphoma. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1996, Volume: 86, Issue:12 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide	1996
Hepatitis C virus-induced leuko-thrombocytopenia and haemolysis. Journal of medical virology, 1997, Volume: 53, Issue:2 Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic	1997
Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1999, Volume: 5, Issue:2 Topics: Adolescent; Child; Child, Preschool; Creatinine; Cyclosporine; Emulsions; Female; Humans; Immunosupp	1999
[The cause of infection as the main or additional cause of death in patients treated for small cell lung cancer]. Pneumonologia i alergologia polska, 1999, Volume: 67, Issue:7-8 Topics: Adult; Aged; Bacterial Infections; Carcinoma, Small Cell; Cause of Death; Comorbidity; Female; Human	1999
Clinical outcome of a protocol to produce immunosuppression in rhesus monkeys (Macaca mulatta): application to infectious disease and gene therapy studies. Journal of medical primatology, 1999, Volume: 28, Issue:6 Topics: Animals; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Genetic Therapy	1999
Central nervous system lupus erythematosus: measurement of cerebrospinal fluid cyclic GMP and other clinical markers of disease activity. Arthritis and rheumatism, 1979, Volume: 22, Issue:5 Topics: Adult; Blood Sedimentation; Central Nervous System Diseases; Cerebrospinal Fluid; Complement System	1979
L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone. Medical and pediatric oncology, 1979, Volume: 6, Issue:2 Topics: Adolescent; Asparaginase; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Hypersensitivity; Dru	1979
Immunoblastic lymphadenopathy with purpura and cryoglobulinemia. Archives of dermatology, 1977, Volume: 113, Issue:5 Topics: Allopurinol; Anemia; B-Lymphocytes; Cryoglobulins; Female; Humans; Leukopenia; Lymphatic Diseases; M	1977
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. Cancer, 1976, Volume: 38, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Cyclophosphamide; Drug Therap	1976
Letter: Monocytopenia after prednisone. The New England journal of medicine, 1975, Apr-24, Volume: 292, Issue:17 Topics: Humans; Leukocyte Count; Leukopenia; Monocytes; Prednisone	1975
Intravascular coagulation in acute lupus erythematosus. JAMA, 1975, Nov-03, Volume: 234, Issue:5 Topics: Acute Disease; Adult; Aspirin; Disseminated Intravascular Coagulation; Female; Headache; Hemolysis;	1975
Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy. International journal of hematology, 1992, Volume: 55, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Enzyme-	1992
[The COP-BLAM therapy for malignant lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos	1990
[Severe pseudotumoral panniculitis in the child: cytophagic histiocytic panniculitis? Favorable outcome with chemotherapy]. Annales de dermatologie et de venereologie, 1990, Volume: 117, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Cyclophosphamide; Diagnosis, Dif	1990
Higher average received relative dose intensities of cyclophosphamide, methotrexate and 5-fluorouracil using a 24-hour method: implications for improved cure rates in breast cancer. Cancer treatment reviews, 1990, Volume: 17, Issue:2-3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administrat	1990
Short term high density systemic therapy for metastatic breast cancer. Breast cancer research and treatment, 1985, Volume: 5, Issue:2 Topics: Altretamine; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Combined Modality Therapy; Doxorubi	1985
Combination chemotherapy only for stage II non-Hodgkin's lymphoma. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide	1986
Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. The New Zealand medical journal, 1989, Jul-26, Volume: 102, Issue:872 Topics: Administration, Oral; Child; Chlorambucil; Cyclophosphamide; Drug Administration Schedule; Drug Eval	1989
Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine. Clinical rheumatology, 1987, Volume: 6, Issue:2 Topics: Adult; Arthritis, Juvenile; Aspirin; Azathioprine; Drug Therapy, Combination; Humans; Leukopenia; Ma	1987
Cytomegalovirus infections in renal transplant recipients. Correlation between clinical disease and results of a specific ELISA. Antiviral research, 1985, Volume: Suppl 1 Topics: Antibodies, Viral; Antilymphocyte Serum; Cyclosporins; Cytomegalovirus; Cytomegalovirus Infections;	1985
Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation, 1988, Volume: 45, Issue:2 Topics: Adult; Azathioprine; Cyclosporins; Female; Graft Rejection; Haplotypes; Histocompatibility Testing;	1988
The anemia of sarcoidosis. Sarcoidosis, 1988, Volume: 5, Issue:1 Topics: Adult; Anemia; Bone Marrow; Female; Granuloma; Humans; Iron; Leukopenia; Lung Diseases; Male; Predni	1988
Primary chemotherapy with mitoxantrone and prednisone in advanced breast carcinoma. A phase II study. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Hu	1988
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas. Tumori, 1987, Feb-28, Volume: 73, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Doxorubic	1987
Factors influencing the incidence of infections in Felty's syndrome. Archives of internal medicine, 1987, Volume: 147, Issue:5 Topics: Arthritis, Rheumatoid; Complement System Proteins; Disability Evaluation; Felty Syndrome; Humans; In	1987
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial. Investigational new drugs, 1987, Volume: 5 Suppl Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols;	1987
Search for eosinopenia in hospitalized patients with normal blood leukocyte concentration. American journal of hematology, 1987, Volume: 24, Issue:1 Topics: Eosinophils; Hospitalization; Humans; Leukocyte Count; Leukopenia; Prednisone; Reference Values	1987
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast cancer research and treatment, 1985, Volume: 5, Issue:2 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neopla	1985
Chlorambucil in steroid-dependent nephrotic syndrome. The Journal of pediatrics, 1973, Volume: 82, Issue:4 Topics: Adolescent; Beta-Globulins; Blood Pressure; Child; Child, Preschool; Chlorambucil; Drug Synergism; F	1973
Long-term assessment of cyclophosphamide therapy for nephrosis in children. Lancet (London, England), 1974, Oct-26, Volume: 2, Issue:7887 Topics: Adolescent; Age Factors; Alopecia; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cystitis	1974
Long-term immunosuppressive therapy of ulcerative colitis. Continuation of a personal series. The American journal of digestive diseases, 1973, Volume: 18, Issue:4 Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Child; Child, Preschool; Colitis, Ulcerative; Female	1973
[Reticulosarcomatosis with immunological phenomena following several years lasting thrombopenia]. Schweizerische medizinische Wochenschrift, 1967, Nov-04, Volume: 97, Issue:44 Topics: Adult; Blood Cell Count; Blood Platelets; Coombs Test; Female; Humans; Leukopenia; Lymphoma, Large B	1967
[On the question of generalized mesenchymal reaction in the glucocorticoid therapy of primary chronic polyarthritis]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1968, Jul-15, Volume: 23, Issue:14 Topics: Arthritis, Rheumatoid; Connective Tissue; Felty Syndrome; Female; Humans; Leg Ulcer; Leukopenia; Mal	1968
Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts. Surgical forum, 1969, Volume: 20 Topics: Animals; Antilymphocyte Serum; Azathioprine; Dogs; gamma-Globulins; Histocompatibility; Immunosuppre	1969
Combination chemotherapy in accelerated phase of chronic granulocytic leukemia. Archives of internal medicine, 1969, Volume: 123, Issue:2 Topics: Adolescent; Adult; Aged; Anemia; Blood Platelets; Blood Transfusion; Blood Urea Nitrogen; Bone Marro	1969
[L-Asparaginase in the treatment of acute leukemia]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1970, Apr-08, Volume: 46, Issue:17 Topics: Acute Disease; Adolescent; Adult; Aged; Asparaginase; Child, Preschool; Drug Hypersensitivity; Drug	1970
Combination chemotherapy in the treatment of advanced Hodgkin's disease. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1973, Jun-02, Volume: 47, Issue:21 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Female; Hodgkin Disease; Humans; Leukopen	1973
Clinical aspects of cytomegalovirus infection in kidney-graft recipients. Scandinavian journal of infectious diseases, 1974, Volume: 6, Issue:4 Topics: Antibodies; Azathioprine; Blood Group Antigens; Blood Transfusion; Complement Fixation Tests; Creati	1974
[Problems of immunosuppressive therapy in human liver transplantation. I]. Bruns' Beitrage fur klinische Chirurgie, 1970, Volume: 218, Issue:2 Topics: Adult; Alkaline Phosphatase; Antilymphocyte Serum; Azathioprine; Bilirubin; Blood Proteins; Diabetes	1970
Combination chemotherapy in disseminated carcinoma of the breast. Oncology, 1974, Volume: 29, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Evaluation Stu	1974
Azathioprine and prednisone. Transplantation proceedings, 1972, Volume: 4, Issue:4 Topics: Azathioprine; Gastrointestinal Hemorrhage; Humans; Immunosuppression Therapy; Injections, Intravenou	1972
Pemphigus treatment with azathioprine. Clinical and immunologic correlation. Archives of dermatology, 1973, Volume: 107, Issue:3 Topics: Adult; Aged; Antibodies; Azathioprine; Blood Platelets; Dose-Response Relationship, Drug; Fatigue; F	1973
Infectious risk factors in the immunosuppressed host. The American journal of medicine, 1973, Volume: 54, Issue:4 Topics: Adolescent; Adult; Agammaglobulinemia; Age Factors; Antilymphocyte Serum; Azathioprine; Child; Femal	1973
Infectious complications in renal transplant recipients. Transplantation proceedings, 1973, Volume: 5, Issue:3 Topics: Acute Kidney Injury; Antilymphocyte Serum; Central Nervous System Diseases; Hepatitis; Humans; Hyper	1973
Lupus erythematosus and porphyria. Coexistence in seven patients. Archives of dermatology, 1973, Volume: 108, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Alcoholism; Antibodies, Antinuclear; Basement Membrane; Complement S	1973
Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas. Scandinavian journal of haematology, 1973, Volume: 10, Issue:3 Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio	1973
Nonketotic hyperglycemia due to prednisone (NSC-10023) following ketotic hyperglycemia due to L-asparaginase (NSC-109229) plus prednisone. Cancer chemotherapy reports, 1972, Volume: 56, Issue:6 Topics: Adolescent; Asparaginase; Diabetic Ketoacidosis; Humans; Hyperglycemia; Leukemia; Leukopenia; Male;	1972
Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Archives of dermatology, 1972, Volume: 106, Issue:5 Topics: Adult; Aged; Alopecia; Cataract; Child; Cyclophosphamide; Diabetes Mellitus; Female; Humans; Leukope	1972
Treatment of advanced Hodgkin's disease with combination chemotherapy. Southern medical journal, 1973, Volume: 66, Issue:7 Topics: Adult; Antineoplastic Agents; Dactinomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma	1973
The use of different drugs and combinations in the treatment of Hodgkin's disease. Series haematologica (1968), 1973, Volume: 6, Issue:2 Topics: Administration, Oral; Anemia; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; I	1973
Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Annals of internal medicine, 1974, Volume: 81, Issue:2 Topics: Adolescent; Adult; Aged; Creatine Kinase; Dermatomyositis; Drug Therapy, Combination; Female; Humans	1974
Azathioprine for pemphigus and pemphigoid--a 4 year follow-up. The British journal of dermatology, 1974, Volume: 91, Issue:1 Topics: Adult; Aged; Anemia; Azathioprine; Bone Neoplasms; Drug Evaluation; Drug Hypersensitivity; Female; F	1974
Five-drug therapy in advanced breast cancer: factors influencing toxicity and response. Cancer, 1974, Volume: 34, Issue:2 Topics: Administration, Oral; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug The	1974
Immunosuppressive therapy of proliferative glomerulonephritis in children. American journal of diseases of children (1960), 1969, Volume: 118, Issue:3 Topics: Adolescent; Autoantibodies; Azathioprine; Child; Complement System Proteins; Creatinine; Female; Flu	1969
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma. Cancer, 1970, Volume: 25, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Benzoates; Bone Marrow; Female; Follow-Up Studies; Humans; Leuko	1970
Cyclic chemotherapy in lymphoma. Cancer, 1971, Volume: 28, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Female	1971
Preleukaemia a report of four cases. Acta haematologica, 1968, Volume: 39, Issue:1 Topics: Adolescent; Aged; Blood Cell Count; Bone Marrow Examination; Epistaxis; Humans; Leukemia; Leukopenia	1968
[Waldenstrom's macroglobulinemia with cutaneous tumor manifestation]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1970, Jul-01, Volume: 25, Issue:13 Topics: Biopsy; Cyclophosphamide; Cytodiagnosis; Female; Glycosides; Humans; Leukopenia; Lymphography; Middl	1970
[Intermittent melphalan-predniso(lo)ne massive-dose therapy of plasmacytoma]. Deutsche medizinische Wochenschrift (1946), 1972, Jan-21, Volume: 97, Issue:3 Topics: Blood Cell Count; Blood Platelets; Drug Combinations; Humans; Leukocyte Count; Leukopenia; Melphalan	1972
Toxicity studies of fluorouracil used with adrenalectomy in breast cancer. Archives of surgery (Chicago, Ill. : 1960), 1972, Volume: 105, Issue:1 Topics: Adrenalectomy; Adult; Aged; Alopecia; Ataxia; Blood Platelet Disorders; Breast Neoplasms; Diarrhea;	1972
[Experiences in administration of antimetabolites in treatment of dermatomyosis]. Dermatologische Monatschrift, 1972, Volume: 158, Issue:7 Topics: Adrenal Cortex Hormones; Adult; Aged; Antimetabolites; Azathioprine; Dermatomyositis; Female; Follow	1972
"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide. JAMA, 1971, Jan-18, Volume: 215, Issue:3 Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Platelets; Blood Transfusion; Cyclophosphamide; Fem	1971
[Vinblastine in the treatment of Hodgkin's disease]. Nordisk medicin, 1971, Dec-16, Volume: 86, Issue:50 Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Leukopenia; Male; Middle Aged; Prednisone;	1971
Systemic lupus erythematosus and acute myeloblastic leukemia. Report of their coexistence and a survey of possible associating features. Archives of internal medicine, 1967, Volume: 120, Issue:3 Topics: Bone Marrow; Chloramphenicol; Female; Hematocrit; Hemoglobinometry; Humans; Leukemia, Myeloid, Acute	1967
Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia. The New England journal of medicine, 1969, Jan-23, Volume: 280, Issue:4 Topics: Antineoplastic Agents; Bone Marrow Examination; Cellulitis; Chemical Phenomena; Chemistry; Child; Da	1969
Treatment of AGL. Archives of internal medicine, 1969, Volume: 123, Issue:2 Topics: Adult; Afibrinogenemia; Aged; Anemia; Antineoplastic Agents; Child; Cytarabine; Daunorubicin; Humans	1969
Bullous eruption and elevated leukocyte alkaline phosphatase in the course of busulfan-treated chronic granulocytic leukemia. Blood, 1970, Volume: 35, Issue:4 Topics: Adult; Alkaline Phosphatase; Arm; Blister; Bone Marrow Examination; Busulfan; Erythema Multiforme; H	1970
Cytarabine. The Medical letter on drugs and therapeutics, 1971, Jan-08, Volume: 13, Issue:1 Topics: Acute Disease; Amino Sugars; Anemia; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell	1971
Efficacy and morbidity of daunomycin (NSC-82151) added to vincristine (NSC-67574) and prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia. Cancer chemotherapy reports, 1971, Volume: 55, Issue:1 Topics: Agranulocytosis; Child; Daunorubicin; Humans; Leukemia, Lymphoid; Leukopenia; Prednisone; Thrombocyt	1971
A primary sideroblastic anemia terminating in bone marrow aplasia. American journal of clinical pathology, 1968, Volume: 50, Issue:4 Topics: Anemia, Sideroblastic; Blood Platelets; Bone Marrow; Bone Marrow Diseases; Bone Marrow Examination;	1968
[Bone marrow lesions caused by chloramphenicol. Case report]. Munchener medizinische Wochenschrift (1950), 1969, Oct-31, Volume: 111, Issue:44 Topics: Anemia, Aplastic; Asthma; Blood Transfusion; Bone Marrow Diseases; Chloramphenicol; Erythrocytes; He	1969
Further experience with splenectomy in Hodgkin's Disease. Journal of surgical oncology, 1969, Volume: 1, Issue:4 Topics: Bone Marrow Examination; Hodgkin Disease; Humans; Hypersplenism; Leukopenia; Methods; Prednisone; Sp	1969
Long-term platelet support of patients with aplastic anemia. Effect of splenectomy and steroid therapy. Annals of internal medicine, 1970, Volume: 73, Issue:1 Topics: Adolescent; Adult; Androgens; Anemia, Aplastic; Antibody Formation; Blood Platelet Disorders; Blood	1970
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease. Blood, 1970, Volume: 36, Issue:6 Topics: Adolescent; Adult; Antimetabolites; Antineoplastic Agents; Benzoates; Child; Female; Hodgkin Disease	1970
[Long-term therapy of chronic hepatitis]. Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1970, Volume: 30, Issue:1 Topics: Adolescent; Adult; Aged; Antacids; Azathioprine; Child; Child, Preschool; Chronic Disease; Diet Ther	1970
[Duration of disease and survival time in plasmacytoma]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1970, Dec-01, Volume: 25, Issue:23 Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Antineoplastic Agents; Blood Urea Nitrogen; Cyclo	1970
Splenectomy in Hodgkin's Disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapy. The American journal of medicine, 1971, Volume: 50, Issue:1 Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases;	1971
Steroid resistance in bronchial asthma. Annals of internal medicine, 1968, Volume: 69, Issue:3 Topics: Adult; Aged; Asthma; Eosinophils; Female; Humans; Hydrocortisone; Injections, Intravenous; Leukocyte	1968
Treatment of ulcerative colitis with azathioprine. British medical journal, 1968, Dec-21, Volume: 4, Issue:5633 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Colitis, Ulcerative; Female; Humans; Leuko	1968
Abnormal (marker) chromosomes in two patients with acute myelofibrosis. Archives of internal medicine, 1969, Volume: 123, Issue:2 Topics: Aged; Anemia; Anti-Bacterial Agents; Blood Cell Count; Blood Cells; Blood Chemical Analysis; Blood T	1969
[Chlorambucil in the treatment of idiopathic nephrotic syndrome without glomrular lesions in childhood. Apropos of 30 cases]. Annales de pediatrie, 1969, Jan-02, Volume: 16, Issue:1 Topics: Adolescent; Anemia; Biopsy; Child; Child, Preschool; Chlorambucil; Female; Glucocorticoids; Humans;	1969
Treatment of refractory idiopathic thrombocytopenic purpura. JAMA, 1969, Mar-17, Volume: 207, Issue:11 Topics: Adult; Aged; Azathioprine; Child; Drug Synergism; Female; Humans; Leukopenia; Male; Middle Aged; Pre	1969
Alkeran and multiple myeloma. The Medical letter on drugs and therapeutics, 1966, Apr-22, Volume: 8, Issue:8 Topics: Anemia; Cyclophosphamide; Humans; Leukopenia; Melphalan; Multiple Myeloma; Prednisone; Urethane	1966

prednisone and Leukocytopenia